Japan's Nikkei rebounds from 5-day losing streak, US economy worries weigh

Japan's Nikkei share aver rebounded from a five-day losing streak on Tuesday as investors scooped up stocks that h fallen too much, although uncertainties about U.S. ecomic outlook capped gains.

Nikkei .N225 was up 0.08 per cent at 36,244.22 points by midday break, after erasing most of its 0.9 per cent gain earlier in session.

broer Topix .TOPX rose 0.34 per cent to 2,588.52.

"Investors scooped up stocks after sell-offs in past several days but market could t be completely bullish as re are many uncertainties, such as outlook of U.S. ecomy," said Fumio Matsumoto, chief strategist at Okasan Securities.

" market view on U.S. ecomy, as well as foreign currency markets, are divided," Matsumoto said.

Techlogy stocks led Nikkei 's gains, with chip-making equipment maker Tokyo Electron 8035.T rising 2.88 per cent to become biggest boost for index.

Techlogy investor SoftBank Group 9984.T rose 0.95 per cent and chip-testing equipment maker vantest 6857.T climbed 0.39 per cent.

"We cant say market has regained momentum until Nikkei rises to around 39,000 level," said Shigetoshi Kama, general manr of research department at Tachibana Securities.

Drug maker Daiichi Sankyo 4568.T tanked 8.56 per cent after trials showed an experimental drug, which drug maker has jointly developed with UK-based AstraZeneca AZN.L, did t significantly improve overall survival in lung cancer patients in a late-st trial.

Joban Kosan 9675.T surged 8 per cent to 1,663 yen after operator of Hawaiian-med resort complex in Fukushima said an investment fund Fortress Investment Group would buy firm for about 14 billion yen ($98 million) in a public tender offer at 1,650 yen.